Growth and adult height in GH-treated children with nonacquired GH deficiency and idiopathic short stature: the influence of pituitary magnetic resonance imaging findings
- PMID: 11600520
- DOI: 10.1210/jcem.86.10.7962
Growth and adult height in GH-treated children with nonacquired GH deficiency and idiopathic short stature: the influence of pituitary magnetic resonance imaging findings
Abstract
We analyzed the final height of 146 short children with either nonacquired GH deficiency or idiopathic short stature. Our purpose was 1) to assess growth according to the pituitary magnetic resonance imaging findings in the 63 GH-treated children with GH deficiency and 2) to compare the growth of the GH-deficient patients with normal magnetic resonance imaging (n = 48) to that of 32 treated and 51 untreated children with idiopathic short stature (GH peak to provocative tests >10 microg/liter). The mean GH dose was 0.44 IU/kg.wk (0.15 mg/kg.wk), given for a mean duration of 4.6 yr. Among the GH-deficient children, 15 had hypothalamic-pituitary abnormalities (stalk agenesis), all with total GH deficiency (GH peak <5 microg/liter). They were significantly shorter and younger at the time of diagnosis than those with normal magnetic resonance imaging, had better catch-up growth (+2.7 +/- 0.9 vs. +1.3 +/- 0.8 SD score; P < 0.01), and reached greater final height (-1.1 +/- 1.0 vs. -1.7 +/- 1.0 SD score; P < 0.05). Among patients with normal magnetic resonance imaging, there was no difference in catch-up growth and final height between partial and total GH deficiencies. GH-deficient subjects with normal magnetic resonance imaging and treated and untreated patients with idiopathic short stature had comparable auxological characteristics, age at evaluation, and target height. Although they had different catch-up growth (+1.3 +/- 0.8, +0.9 +/- 0.6, and +0.7 +/- 0.9 SD score, respectively; P < 0.01, by ANOVA), these patients reached a similar final height (-1.7 +/- 1.0, -2.1 +/- 0.8, and -2.1 +/- 1.0 SD score, respectively; P = 0.13). Pituitary magnetic resonance imaging findings show the heterogeneity within the group of nonacquired GH deficiency and help to predict the response to GH treatment in these patients. The similarities in growth between the GH-deficient children with normal magnetic resonance imaging and those with idiopathic short stature suggest that the short stature in the former subjects is at least partly due to factors other than GH deficiency.
Similar articles
-
Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.Clin Endocrinol (Oxf). 2003 May;58(5):647-52. Clin Endocrinol (Oxf). 2003. PMID: 12699449
-
Do all patients with childhood-onset growth hormone deficiency (GHD) and ectopic neurohypophysis have persistent GHD in adulthood?J Clin Endocrinol Metab. 2005 Feb;90(2):650-6. doi: 10.1210/jc.2004-1274. Epub 2004 Nov 16. J Clin Endocrinol Metab. 2005. PMID: 15546901
-
Growth hormone (GH) secretion and pituitary size in children with short stature. Efficacy of GH therapy in GH-deficient children, depending on the pituitary size.Neuro Endocrinol Lett. 2005 Oct;26(5):447-52. Neuro Endocrinol Lett. 2005. PMID: 16264418 Clinical Trial.
-
Growth velocity, final height and bone mineral metabolism of short children treated long term with growth hormone.Curr Pharm Biotechnol. 2000 Jul;1(1):33-46. doi: 10.2174/1389201003378997. Curr Pharm Biotechnol. 2000. PMID: 11467359 Review.
-
Magnetic resonance images of 91 children with different causes of short stature: pituitary size reflects growth hormone secretion.Eur J Pediatr. 1997 Oct;156(10):758-63. doi: 10.1007/s004310050707. Eur J Pediatr. 1997. PMID: 9365063 Review.
Cited by
-
A randomized pilot trial of growth hormone with anastrozole versus growth hormone alone, starting at the very end of puberty in adolescents with idiopathic short stature.Int J Pediatr Endocrinol. 2015;2015(1):4. doi: 10.1186/1687-9856-2015-4. Epub 2015 Feb 16. Int J Pediatr Endocrinol. 2015. PMID: 25972902 Free PMC article.
-
Growth hormone significantly increases the adult height of children with idiopathic short stature: comparison of subgroups and benefit.Int J Pediatr Endocrinol. 2014;2014(1):15. doi: 10.1186/1687-9856-2014-15. Epub 2014 Jul 16. Int J Pediatr Endocrinol. 2014. PMID: 25075207 Free PMC article.
-
GH Therapy in Non-Growth Hormone-Deficient Children.Children (Basel). 2024 Dec 24;12(1):3. doi: 10.3390/children12010003. Children (Basel). 2024. PMID: 39857834 Free PMC article. Review.
-
Diagnosis of growth hormone deficiency in childhood.Curr Opin Endocrinol Diabetes Obes. 2012 Feb;19(1):47-52. doi: 10.1097/MED.0b013e32834ec952. Curr Opin Endocrinol Diabetes Obes. 2012. PMID: 22157400 Free PMC article. Review.
-
Pituitary stalk interruption syndrome in Chinese people: clinical characteristic analysis of 55 cases.PLoS One. 2013;8(1):e53579. doi: 10.1371/journal.pone.0053579. Epub 2013 Jan 14. PLoS One. 2013. PMID: 23341953 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources